Szalai Alexander J
Division of Clinical Immunology and Rheumatology, Department of Medicine, University of Alabama at Birmingham, THT 437B, Birmingham, AL 35294-0006, USA.
Vascul Pharmacol. 2002 Aug;39(3):105-7. doi: 10.1016/s1537-1891(02)00294-x.
We have obtained data from various investigations that firmly establishes an important host defense function for human C-reactive protein (CRP). In transgenic mice, the beneficial effect of CRP depends largely on its ability to recruit complement, Fc gamma receptors and the adaptive immune system; but this function is not limited to the blood-borne protein nor does it require a substantial rise in blood CRP levels. Moreover, in clinical studies, we have observed that differences in baseline levels of CRP among individuals correlate with a polymorphism in the CRP gene. The relevance of this finding is underlined by the observation that subtle elevation of blood CRP is associated with significantly increased risk of cardiac disease.